There are errors in the data in Figure 6C and Supplementary Figure 2 showing the Kaplan-Meier analyses of the overall survival of bladder cancer patients from the TCGA cohort. The original figures had shown that the low miR-199a-1, miR-199a-2, and miR199b expression groups (n ¼ 202) had significantly lower overall survival rates than patients with high expression of these premiRNA groups (n ¼ 202) ( Figure 6C ) and that patients in the high ITGA3 expression group (n ¼ 134) exhibited lower overall survival rates compared with those in the low expression group (n ¼ 134) (Supplementary Figure 2) .
There was an error in the categorisation of the patients who died, and they were categorised as 'censored', although they should have been 'uncensored'. Reanalysis of the data found no significant differences in overall survival between high and low expression groups (amended Figure This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons AttributionNonCommercial-Share Alike 4.0 Unported License. Negative correlations between ITGA3 expression and miR-199a-1, miR-199a-2, and miR-199b expression in BC tissues (P=0.0099, R= À 0.128; P=0.0189, R= À 0.117; and P=0.033, R= À 0.106, respectively). (C) Kaplan-Meier analysis showed no significant differences in overall survival rates between the groups of low and high expression levels of miR-199a-1, miR-199a-2, and miR-199b frosm the TCGA cohort.
